Stock Movers: JM Smucker Falls, McDonald's Drops, Novo Nordisk Gains

JM Smucker's Coffee Cost Woes

• 📉 JM Smucker shares dropped 13% following a report of increased coffee costs due to US tariffs, estimated to impact earnings by $1 per share.
• ☕ The company, which owns Folgers and Cafe Bustelo, has already raised coffee prices three times since last June and plans another increase in August, potentially hurting demand.

McDonald's Faces Headwinds from Weight-Loss Drugs

• 🍔 McDonald's shares fell 1.5% after Redburn Atlantic issued a 'sell' rating, citing concerns over shifting consumer patterns due to weight-loss drugs and inflation.
• 💊 Analysts estimate that GLP-1 drugs like Ozempic could reduce McDonald's annual revenue by $428 million, with potential for greater impact over time.
• 📊 Despite the downgrade, McDonald's maintains a largely positive analyst rating, with 22 buy-equivalent ratings and an average price target of $332.

Novo Nordisk Rises on Parvus Stake Report

• 📈 Novo Nordisk shares surged nearly 5% to a two-month high following a report that activist hedge fund Parvus Asset Management has acquired a stake.
• 🤝 Parvus is reportedly interested in influencing the appointment of a new CEO, as Novo Nordisk prepares to replace its current CEO, Lars Fruergaard Jorgensen.
• 💡 Novo Nordisk's GLP-1 drugs, such as Ozempic and Wegovy, have become household names, but the company has faced challenges competing with rivals.